Literature DB >> 15358108

Activation of nuclear factor-kappaB and its proinflammatory mediator cascade in the infarcted rat heart.

Li Lu1, Sue S Chen, John Q Zhang, Felix J Ramires, Yao Sun.   

Abstract

Nuclear transcription factor (NF)-kappaB regulates inflammatory and immune responses by increasing the expression of specific inflammatory genes in various tissues. Whether the infarcted heart includes the activation of NF-kappaB and a proinflammatory mediator cascade that it regulates has not been fully explored. Herein, we monitored the temporal and spatial activation of NF-kappaB, together with expression of tumor necrosis factor (TNF)-alpha, vascular cell adhesion molecule-1 (VCAM-1), and transforming growth factor (TGF)-beta(1), in the infarcted rat heart at and remote to MI from day 3 to day 28 following left coronary artery ligation. Compared to the normal heart, we observed NF-kappaB activation, together with the elevated expression of VCAM-1 in endothelial cells, TNF-alpha and TGF-beta(1) in inflammatory cells at sites of repair in the infarcted heart, which started on day 3, peaked on day 7, and gradually declined thereafter. Our findings suggest NF-kappaB activation and its proinflammatory mediator cascade are contributory to the inflammatory response and remodeling that appear at various sites of repair in the infarcted rat heart.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358108     DOI: 10.1016/j.bbrc.2004.07.048

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction.

Authors:  Yu-Yu Yao; Hang Yin; Bo Shen; Lee Chao; Julie Chao
Journal:  Regul Pept       Date:  2006-12-28

2.  Cardiac magnetic resonance imaging of rapid VCAM-1 up-regulation in myocardial ischemia-reperfusion injury.

Authors:  Stuart M Grieve; Jacob Lønborg; Jawad Mazhar; Timothy C Tan; Edwin Ho; Chia-Chi Liu; William Lay; Anthony J Gill; Philip Kuchel; Ravinay Bhindi; Gemma A Figtree
Journal:  Eur Biophys J       Date:  2012-09-28       Impact factor: 1.733

Review 3.  Myocardial repair/remodelling following infarction: roles of local factors.

Authors:  Yao Sun
Journal:  Cardiovasc Res       Date:  2008-12-02       Impact factor: 10.787

Review 4.  Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Mediators Inflamm       Date:  2010-04-12       Impact factor: 4.711

5.  Modification of oxidative stress on gene expression profiling in the rat infarcted heart.

Authors:  Wenyuan Zhao; Tieqiang Zhao; Yuanjian Chen; Yanhua Qu; Ivan C Gerling; Yao Sun
Journal:  Mol Cell Biochem       Date:  2013-04-06       Impact factor: 3.396

6.  Reactive oxygen species promote angiogenesis in the infarcted rat heart.

Authors:  Wenyuan Zhao; Tieqiang Zhao; Yuanjian Chen; Robert A Ahokas; Yao Sun
Journal:  Int J Exp Pathol       Date:  2009-09-15       Impact factor: 1.925

Review 7.  Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction.

Authors:  Yao Sun
Journal:  J Mol Cell Cardiol       Date:  2009-08-12       Impact factor: 5.000

8.  Reactive oxygen species-targeted therapeutic interventions for atrial fibrillation.

Authors:  Ali A Sovari; Samuel C Dudley
Journal:  Front Physiol       Date:  2012-08-06       Impact factor: 4.566

9.  Effects of thalidomide on the expression of adhesion molecules in rat liver cirrhosis.

Authors:  Peng Lv; Shelley Chireyath Paul; Yanjv Xiao; Shiquan Liu; Hesheng Luo
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

10.  Blueberry Extracts as a Novel Approach to Prevent Ozone-Induced Cutaneous Inflammasome Activation.

Authors:  Erika Pambianchi; Francesca Ferrara; Alessandra Pecorelli; Brittany Woodby; Mary Grace; Jean-Philippe Therrien; Mary Ann Lila; Giuseppe Valacchi
Journal:  Oxid Med Cell Longev       Date:  2020-08-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.